CD59 and neoplasm: Previous studies had shown that CD59 was highly expressed in a variety of solid tumors and cells, acting as a complement regulatory protein that prevented MAC formation by binding to C8 or C9, thereby protecting tumor cells from complement-mediated cytolysis and evading immune detection.